Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and pharmacokinetics of a single intraarticular dose of 4P004 in patients with knee osteoarthritis (KL 2-4); resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• 4P004

Snippet

Sponsor: 4Moving Biotech | Conditions: Knee Osteoarthritis | Phase 1 | Status: COMPLETED | Results posted: 2025-05-15